Search Results 641-650 of 13488 for 📏加🍌line:sammibaby🍌了解力曼直銷🐫很瘦平胸怎麼豐胸🍛產後營養瘦身🎗新竹市腹肌贴有用吗🏷新兴区win7瘦身🛩️暴走多久才有減肥效果🐫kitty强力瘦身操2😘力量直銷
Title: A Phase 1B, Multi-Center, Open-Label Study of Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-Cell Lymphoma and Follicular ...
Title: A Multicenter Open-label Extension Study to Evaluate the Long-term Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic- ...
Title: A Phase II Randomized Study Comparing Ibrutinib and Rituximab vs. Venetoclax and Rituximab in Previously Untreated Waldenström's Macroglobulinemia ...
Title: A Phase 1, Single-arm, Prospective Study to Evaluate the Treatment of Genitourinary Syndrome of Menopause with Platelet Rich Plasma (PRP) in Women with a ...
Rochester, Minn. The purpose of this research study is to improve our understanding of normal liver and gallbladder function and liver and gallbladder diseases ...
Title: An Open-label, Prospective, Multicenter Study to Assess the SAfety of Regional Citrate Anticoagulation Delivered by the multiFiltratePRO system in ...
... Label Fixed-Dose Study in Patients with Autosomal Dominant Polycystic Kidney Disease to Evaluate the Safety, Tolerability, Pharmacodynamics, and ...
Title: STATUS STUDY: Pilot Open-Label Trial of Intravenous Erenumab in Patients with Status Migrainosus · Title: Effect of Medically-tailored Meal Delivery ...
Title: An Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin (RBV) in Treatment ...
POC ID: CLS-20567464; Title: A Phase I/II Open-Label Study to Evaluate the Safety, Cellular Kinetics and Efficacy of AZD5851, a Chimeric Antigen Receptor T ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.